How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?

Abstract

IntroductionDespite the continuous improvement of the quality of lipid lowering therapy the achievement of target values is still not satisfactory, mainly in the very high cardiovascular risk category patients, where the goal of low density lipoprotein cholesterol (LDL-C) is 1.80 mmol/l.Material and methodsThe trends in lipid lowering treatment of 17420 patients from different studies conducted between 2004 and 2010 were compared to that of 1626 patients of MULTI GAP (MULTI Goal Attainment Problem) 2011 treated by general practitioners (GPs) and specialists.ResultsIn MULTI GAP 2011 the mean LDL-C level ± SD) of patients treated by GPs was found to be 2.87 ±1.01 mmol/l, the target value of 2.50 was achieved by 40% of them, in the specialists’ patients the mean LDL-C level proved to be 2.77 ±1.10 mmol/l and the achievement rate was 45%. In the 2.50 mmol/l achievement rate of GPs’ patients a satisfactory improvement was observed in the studied years, but the 1.80 mmol/l LDL-C goal in 2011 was attained only in 11% of very high risk cases. There was a linear correlation between the patient compliance estimated by the physicians and the LDL-C achievement rate.ConclusionsAs the number of very high risk category patients has been increased according to the new European dyslipidemia guidelines, growing attention needs to be placed on attainment of the 1.80 mmol/l LDL-C level. Based on the results of the MULTI GAP studies, improving patients’ adherence and the continuous training of physicians are necessary.

Persistence with statin therapy in Hungary

“…The importance of lipid-lowering therapy is well established [4, 5]. Regarding the Hungarian lipid goal achievement rates in recent years there are significant improvements, but the result is still far from expectations [6–8]. In a 2007 summary of 14 key clinical trials of lipid lowering conducted since 2004 and involving 90 056 individuals [9].…”

Safety and effectiveness of combined antihypertensive and cholesterol-lowering therapy in high-/very high-risk patients

“…The proportion of high-risk patients reaching target LDL-C levels in Hungary increased from 14% in 2004 to 40% in 2011, according to general practice data [33,34]. This increase is noteworthy, but 60% of patients (and an even greater percentage of patients at very high CV risk) still do not achieve target values.…”

State of the art paper Improvement of hepatic bioavailability as a new step for the future of statin

“…Low-density lipoproteins (LDL) are known to be a major means of transport of cholesterol in human blood [ 2 ]. An overwhelming number of epidemiological studies suggest that elevated levels of LDL and total cholesterol in blood are linked to increased incidence of cardiovascular disease and higher mortality of cardiovascular patients [ 3 , 4 ]. On the other hand, reduced LDL and total cholesterol values confer lower occurrence of atherosclerosis, stroke and myocardial infarction in patients with atherosclerosis and peripheral artery disease [ 5 – 7 ].…”